Healthcare provider profile · identity verified

James Robert Rummel, D.O.

Family Practice · SHARON, PA · NPI 1346520525

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	294	49
Levothyroxine Sodium	Levothyroxine Sodium	287	59
Pantoprazole Sodium	Pantoprazole Sodium	274	69
Metoprolol Succinate	Metoprolol Succinate	235	45
Lisinopril	Lisinopril	231	52
Furosemide	Furosemide	223	37
Atorvastatin Calcium	Atorvastatin Calcium	212	56
Famotidine	Famotidine	182	31
Duloxetine Hcl	Duloxetine Hcl	167	27
Rosuvastatin Calcium	Rosuvastatin Calcium	161	50
Potassium Chloride	Potassium Chloride	156	31
Metoprolol Tartrate	Metoprolol Tartrate	118	24
Amlodipine Besylate	Amlodipine Besylate	114	31
Eliquis	Apixaban	106	19
Pravastatin Sodium	Pravastatin Sodium	102	37
Celecoxib	Celecoxib	100	20
Mirtazapine	Mirtazapine	100	15
Buspirone Hcl	Buspirone Hcl	96	15
Allopurinol	Allopurinol	81	16
Sertraline Hcl	Sertraline Hcl	81	18
Ozempic	Semaglutide	79	14
Trazodone Hcl	Trazodone Hcl	79	12
Escitalopram Oxalate	Escitalopram Oxalate	78	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	78	14
Lamotrigine	Lamotrigine	76	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	76	19
Ropinirole Hcl	Ropinirole Hcl	72	suppressed
Spironolactone	Spironolactone	71	12
Amitriptyline Hcl	Amitriptyline Hcl	70	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	63	23
Lorazepam	Lorazepam	62	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	61	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	60	11
Clopidogrel	Clopidogrel Bisulfate	59	11
Topiramate	Topiramate	58	suppressed
Synjardy	Empagliflozin/Metformin Hcl	54	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	51	27
Metformin Hcl	Metformin Hcl	50	12
Olanzapine	Olanzapine	50	suppressed
Xarelto	Rivaroxaban	50	suppressed
Omeprazole	Omeprazole	49	22
Buprenorphine	Buprenorphine	48	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	48	12
Alendronate Sodium	Alendronate Sodium	47	suppressed
Jardiance	Empagliflozin	47	13
Meloxicam	Meloxicam	47	suppressed
Belsomra	Suvorexant	44	suppressed
Valsartan	Valsartan	43	suppressed
Montelukast Sodium	Montelukast Sodium	42	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	42	suppressed
Insulin Aspart Flexpen	Insulin Aspart	39	suppressed
Pregabalin	Pregabalin	39	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	38	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Carvedilol	Carvedilol	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Tramadol Hcl	Tramadol Hcl	37	15
Trulicity	Dulaglutide	37	suppressed
Baclofen	Baclofen	35	suppressed
Bumetanide	Bumetanide	35	suppressed
Gemtesa	Vibegron	35	11
Simvastatin	Simvastatin	35	13
Fluticasone Propionate	Fluticasone Propionate	33	14
Losartan Potassium	Losartan Potassium	33	12
Insulin Lispro Kwikpen U-100	Insulin Lispro	32	suppressed
Prednisone	Prednisone	32	16
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	30	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	29	suppressed
Clonazepam	Clonazepam	29	suppressed
Finasteride	Finasteride	28	suppressed
Metformin Hcl Er	Metformin Hcl	28	suppressed
Nystatin	Nystatin	28	15
Lithium Carbonate	Lithium Carbonate	27	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Linzess	Linaclotide	26	suppressed
Loperamide	Loperamide Hcl	26	12
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Torsemide	Torsemide	25	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Divalproex Sodium	Divalproex Sodium	24	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Risperidone	Risperidone	23	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Novofine 32	Pen Needle, Diabetic	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Atenolol	Atenolol	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Glipizide	Glipizide	20	suppressed
Metolazone	Metolazone	20	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Prazosin Hcl	Prazosin Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Alogliptin	Alogliptin Benzoate	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Methylprednisolone	Methylprednisolone	17	15
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	16	16
Ezetimibe	Ezetimibe	16	suppressed
Lactulose	Lactulose	16	suppressed
Lamotrigine Er	Lamotrigine	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Alogliptin-Metformin	Alogliptin Benz/Metformin Hcl	15	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Praluent Pen	Alirocumab	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Brilinta	Ticagrelor	13	suppressed
Cephalexin	Cephalexin	13	11
Doxycycline Hyclate	Doxycycline Hyclate	13	11
Flecainide Acetate	Flecainide Acetate	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Mesalamine Er	Mesalamine	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Mirabegron Er	Mirabegron	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Primidone	Primidone	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Adalimumab-Fkjp(Cf) Pen	Adalimumab-Fkjp	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Ofev	Nintedanib Esylate	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Unifine Pentips	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error